lystn

Topical corticosteroids (TCS) use is controversial in our community and generates a lot of concern among caregivers. Yet, it is the mainstay of eczema treatment for children and nearly every child who sees a doctor for eczema is likely using topical steroids. TCS do usually help with eczema symptoms, but it can be hard to wean off them and then there are side effects. In the first segment, we talk with dermatologist Dr. Steven Feldman from Wake Forest Baptist in North Carolina and two eczema parents who had very different experiences with topical corticosteroids. In the second segment, we discuss the very latest findings on steroid use with UK dermatology nurse Sandra Lawton who is a contributing author on the 2022 Cochrane Review, "What is the best way to use topical corticosteroids to treat people with eczema". (Please consider supporting our podcast, with a tax deductible donation) https://interland3.donorperfect.net/weblink/weblink.aspx?id=3&name=E357477 (https://interland3.donorperfect.net/weblink/weblink.aspx?id=3&name=E357477) . Research related to this episode: What is the best way to use topical corticosteroids to treat people with eczema? https://www.cochrane.org/CD013356/SKIN_what-best-way-use-topical-corticosteroids-treat-people-eczema (https://www.cochrane.org/CD013356/SKIN_what-best-way-use-topical-corticosteroids-treat-people-eczema) Combined antibiotic, steroid and moisturizer for atopic dermatitis https://onlinelibrary.wiley.com/doi/10.1111/pde.14458 (https://onlinelibrary.wiley.com/doi/10.1111/pde.14458) Topical steroid withdrawal reactions: a review of the evidence https://www.gov.uk/government/publications/topical-steroid-withdrawal-reactions-a-review-of-the-evidence/topical-steroid-withdrawal-reactions-a-review-of-the-evidence?fbclid=IwAR0SERPj4RVykRAf9SRJ2BIRGUq1_NbiZ34hE_5BDxdzPrfmsrGDAcCN9VE (https://www.gov.uk/government/publications/topical-steroid-withdrawal-reactions-a-review-of-the-evidence/topical-steroid-withdrawal-reactions-a-review-of-the-evidence?fbclid=IwAR0SERPj4RVykRAf9SRJ2BIRGUq1_NbiZ34hE_5BDxdzPrfmsrGDAcCN9VE)